Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12503-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12503-1-AP, RRID:AB_2234144
- Product name
- Kir4.1 antibody
- Antibody type
- Polyclonal
- Description
- Kir4.1 antibody (Cat. #12503-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Yigan Mingmu Decoction inhibits diabetic macular edema through regulating Kir4.1/AQP4 axis: a study based on network pharmacology.
A novel model of subretinal edema induced by DL-alpha aminoadipic acid.
Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation.
Low reliability of anti-KIR4.1(83-120) peptide auto-antibodies in multiple sclerosis patients.
Wnt/β-catenin signaling mediates the seizure-facilitating effect of postischemic reactive astrocytes after pentylenetetrazole-kindling.
Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.
Huang L, Guo X, Hu Q, Hu Z, Wu P, Jiang J, Liu J, Liu Z, Chen X
American journal of translational research 2023;15(11):6362-6380
American journal of translational research 2023;15(11):6362-6380
A novel model of subretinal edema induced by DL-alpha aminoadipic acid.
Xie Z, Wu X, Cheng R, Huang J, Wang X, Shi Q, Xu B, Paulus YM, Yuan S, Liu Q
Experimental eye research 2023 Mar;228:109388
Experimental eye research 2023 Mar;228:109388
Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation.
Curry RN, Aiba I, Meyer J, Lozzi B, Ko Y, McDonald MF, Rosenbaum A, Cervantes A, Huang-Hobbs E, Cocito C, Greenfield JP, Jalali A, Gavvala J, Mohila C, Serin Harmanci A, Noebels J, Rao G, Deneen B
Neuron 2023 Mar 1;111(5):682-695.e9
Neuron 2023 Mar 1;111(5):682-695.e9
Low reliability of anti-KIR4.1(83-120) peptide auto-antibodies in multiple sclerosis patients.
Marino M, Frisullo G, Di Sante G, Samengo DM, Provenzano C, Mirabella M, Pani G, Ria F, Bartoccioni E
Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Jun;24(7):910-918
Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Jun;24(7):910-918
Wnt/β-catenin signaling mediates the seizure-facilitating effect of postischemic reactive astrocytes after pentylenetetrazole-kindling.
Yang J, Zhang X, Wu Y, Zhao B, Liu X, Pan Y, Liu Y, Ding Y, Qiu M, Wang YZ, Zhao G
Glia 2016 Jun;64(6):1083-91
Glia 2016 Jun;64(6):1083-91
Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.
Minkel HR, Anwer TZ, Arps KM, Brenner M, Olsen ML
Glia 2015 Dec;63(12):2285-97
Glia 2015 Dec;63(12):2285-97
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The Kir4.1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human Kir4.1. This antibody recognizes human,mouse,rat antigen. The Kir4.1 antibody has been validated for the following applications: ELISA, WB analysis.